|
21
|
|
|
PPT2-EGFL8 readthrough (NMD candidate) |
PPT-2, PPT2 |
|
|
22
|
|
|
P2RX5-TAX1BP3 readthrough (NMD candidate) |
P2RX5, P2X5 |
|
|
23
|
|
|
PRICKLE2 antisense RNA 1 |
- |
|
|
24
|
|
|
Prostate cancer associated transcript 1 |
PCA1, PCAT-1, PiHL |
Breast cancer, Breast carcinoma, Colonic neoplasms, Colorectal adenoma, Colorectal cancer, Colorectal neoplasms, Esophagus neoplasm, Hypothyroidism, Intracranial aneurysm, Lymphocytic leukemia, Multiple myeloma, Multiple sclerosis, Nasopharyngeal carcinoma, Prostatic neoplasms, Prostate cancer |
|
25
|
|
|
Protein tyrosine phosphatase receptor type U |
FMI, PCP-2, PTP, PTP-J, PTP-PI, PTP-RO, PTPPSI, PTPRO, PTPU2, R-PTP-PSI, R-PTP-U, hPTP-J |
|
|
26
|
|
|
Polyglutamine binding protein 1 |
MRX2, MRX55, MRXS3, MRXS8, NPW38, RENS1, SHS |
Anxiety disorder, Arachnodactyly, Atrial septal defect, Brachycephaly, Camptodactyly of fingers, Cataract, Cerebral atrophy, Charcot-marie-tooth disease, Colorectal cancer, Congenital camptodactyly, Congenital epicanthus, Congenital microcephaly, Congenital ocular coloboma, Congenital pectus excavatum, Developmental delay, Dwarfism, Dysmorphic features, Hamel cerebro-palato-cardiac syndrome, High palate, Hyperopia, Hypospadias, Imperforate anus, Spastic diplegia, Macroglossia, Macrotia, Malocclusion, Mental retardation, Mental retardation, x-linked, Microcephaly, Micrognathism, Microlissencephaly, Microstomia, Nail dystrophy, Partial agenesis of corpus callosum, Persistent ostium primum, Renpenning syndrome, Scoliosis, Secundum atrial septal defect, Situs inversus, Spastic paraplegia, Strabismus, Tetralogy of fallot, Ventricular septal defect, Hereditary spastic paraplegia, x-linkedView all (29 more) |
|
27
|
|
|
PTCHD1 and PHEX antisense RNA |
DDX53-AS1, PHEX-AS1, PTCHD1AS1, PTCHD1AS2 |
|
|
28
|
|
|
Papillary thyroid carcinoma susceptibility candidate 3 |
- |
|
|
29
|
|
|
PITX1 antisense RNA 1 |
C5orf66 |
|
|
30
|
|
|
PIGY upstream open reading frame |
NDUFAFQ, PREY |
|
